Indaco Venture Partners

Indaco Venture Partners SGR is the Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics and robotics, medtech, digital, and new materials. The company focused on growth-stage companies whose competitive advantage stems from cutting-edge proprietary technologies and innovations. In terms of teams and technologies, the focus is on Italian enterprises, although investments are made throughout Europe, the USA, Canada, and Israel. Indaco Venture Partners was founded in 2018 and is headquartered in Milan, Lombardia, Italy.

Alvise Bonivento Ph.D

Co-Founder, Investment Director and Board Member

Calcagno, Cosimo

Investment Manager

Lukas Hill

Investment Manager

Adriana Piccitto

Investment Manager

Carlo Sanfilippo

Senior Investment Manager

Davide Turco

Managing Director and Founder

Zanolo, Simone

Venture Partner

Past deals in Adriatic

InnovHeart

Series C in 2022
InnovHeart is a medical equipment manufacturing company that specializes in developing transcatheter mitral valve replacement systems. The company focuses on creating innovative implant technologies designed to treat patients with mitral valve disease. Its products aim to provide a safe, effective, and user-friendly solution for replacing incompetent mitral valves, allowing hospitals to address heart valve dysfunction more efficiently.

Cellply

Venture Round in 2021
Cellply is a life-science company dedicated to advancing personalized cancer treatment through the development of innovative analytical tools. The company focuses on creating next-generation diagnostic platforms that enable deep characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics. By utilizing proprietary microfluidic technologies and Co-Culture Array technology, Cellply offers highly automated analytical instruments that combine AI-powered image and data analytics. This approach allows for the precise definition of immune system functions at the single-cell level, facilitating the monitoring of clinical responses to treatments. By automating quality control and supporting research and development processes, Cellply aims to enhance the understanding and effectiveness of novel cancer therapies, ultimately improving patient outcomes.

Cortilia

Series C in 2021
Cortilia is an online grocery delivery service based in Milan, Italy, that connects consumers directly with local farmers. Founded in 2011, the company focuses on providing fresh, artisanal, and seasonal products while promoting the local economy. By aggregating farmers in virtual markets, Cortilia minimizes waste and ensures that customers receive high-quality goods delivered to their door within a few hours. This sustainable approach allows consumers to easily access farm and dairy products, enhancing the overall shopping experience while supporting regional agriculture.

WISE

Series C in 2020
WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.

InnovHeart

Series B in 2020
InnovHeart is a medical equipment manufacturing company that specializes in developing transcatheter mitral valve replacement systems. The company focuses on creating innovative implant technologies designed to treat patients with mitral valve disease. Its products aim to provide a safe, effective, and user-friendly solution for replacing incompetent mitral valves, allowing hospitals to address heart valve dysfunction more efficiently.

Enthera

Series A in 2020
Enthera is an Italian biotech start-up focused on developing innovative therapeutic solutions for diabetes, gastrointestinal complications, and other intestinal disorders linked by shared biological pathways. Established in October 2016 through a partnership between BiovelocITA and scientists Prof. Paolo Fiorina and Dr. Francesca D’Addio, Enthera aims to address auto-immune disorders by targeting pathways involved in cell apoptosis across the gut, pancreas, and other organs. This approach seeks to enhance treatment options for challenging conditions such as type 1 diabetes and inflammatory bowel disease, thereby contributing to advancements in the management of intractable autoimmune diseases.

Expert.ai

Post in 2020
Expert.ai is a developer of enterprise natural language processing (NLP) technologies that focuses on transforming language-intensive processes into actionable insights. The company's platform combines symbolic human-like comprehension with machine learning, enabling organizations to enhance decision-making across various sectors, including insurance, banking, publishing, defense, and life sciences. Key offerings include Cogito Discover, a software that utilizes artificial intelligence for analytics, extraction, and categorization of text from various formats, and the Clinical Research Navigator, which assists biomedical clients in researching therapies for infectious diseases. Expert.ai provides its solutions through on-premise, private, and public cloud options, facilitating the adoption of AI technologies and streamlining data science capabilities for a diverse range of industries.

D-Orbit

Series C in 2019
D-Orbit S.r.l. is an Italian New Space company founded in 2011 and headquartered in Sesto Fiorentino, Italy. The company specializes in providing solutions for satellite design, development, launch, commissioning, and decommissioning, with a focus on enabling the safe disposal of artificial satellites to mitigate space debris. D-Orbit offers a range of services, including last-mile delivery of satellites, orbital transportation, and space logistics, aimed at optimizing operations both in orbit and on the ground. By streamlining all phases of a satellite mission, D-Orbit enhances spacecraft design, reliability, and resource utilization while reducing operational costs. The company operates with a commitment to social benefit and environmental sustainability, catering to the needs of satellite owners and operators in a rapidly evolving space marketplace. With approximately 35 employees, D-Orbit also has subsidiaries in Washington, DC, and Lisbon, Portugal.

D-Orbit

Series B in 2019
D-Orbit S.r.l. is an Italian New Space company founded in 2011 and headquartered in Sesto Fiorentino, Italy. The company specializes in providing solutions for satellite design, development, launch, commissioning, and decommissioning, with a focus on enabling the safe disposal of artificial satellites to mitigate space debris. D-Orbit offers a range of services, including last-mile delivery of satellites, orbital transportation, and space logistics, aimed at optimizing operations both in orbit and on the ground. By streamlining all phases of a satellite mission, D-Orbit enhances spacecraft design, reliability, and resource utilization while reducing operational costs. The company operates with a commitment to social benefit and environmental sustainability, catering to the needs of satellite owners and operators in a rapidly evolving space marketplace. With approximately 35 employees, D-Orbit also has subsidiaries in Washington, DC, and Lisbon, Portugal.

Newronika

Series A in 2019
Newronika is a company focused on restoring brain and body functions through innovative neuro-modulation technologies. It develops therapeutic devices that utilize a retro-activity system to record brain activity and modulate neuro-stimulation. By collecting, analyzing, and interpreting bio-signals, Newronika enables patients to receive timely stimulation, allowing them to engage in normal daily activities and enhance their quality of life. As a spin-off from prominent Italian research institutions, including the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika benefits from a multidisciplinary team of experts in various fields such as neuroscience, neurophysiology, biomedical engineering, and neuropsychology.

Cortilia

Series B in 2019
Cortilia is an online grocery delivery service based in Milan, Italy, that connects consumers directly with local farmers. Founded in 2011, the company focuses on providing fresh, artisanal, and seasonal products while promoting the local economy. By aggregating farmers in virtual markets, Cortilia minimizes waste and ensures that customers receive high-quality goods delivered to their door within a few hours. This sustainable approach allows consumers to easily access farm and dairy products, enhancing the overall shopping experience while supporting regional agriculture.

BiovelocITA

Venture Round in 2019
BiovelocITA is a business accelerator focused on fostering the growth of the Italian biotechnology market. Co-founded by Sofinnova Partners, a prominent entity in Italy's biotech sector, BiovelocITA aims to support early-stage biotech companies through a range of services. The organization connects talented scientists, entrepreneurs, and experienced investors to facilitate the creation of innovative ventures. Its programs offer essential resources, including workspace, mentorship, and initial funding, to help start-ups develop viable business plans and achieve success in a competitive landscape. By leveraging its extensive network and expertise, BiovelocITA plays a significant role in strengthening Italy’s position within the European biotechnology market.

MainStreaming

Series B in 2019
MainStreaming specializes in advanced video streaming technology that enables efficient and high-quality delivery of live and on-demand content. The company utilizes EDGE networks to provide broadcast-grade live video services, catering to some of the largest live streaming operations. Its solutions include an API library for seamless integration across multiple devices, enabling broadcasters to track content performance and audience engagement effectively. MainStreaming addresses the challenges of streaming to millions of simultaneous users by optimizing the delivery process, mitigating congestion, and ensuring secure and reliable viewing experiences. Through its innovative approach, MainStreaming enhances the overall quality of service and maximizes return on investment for its clients in the media sector.

Sweetguest

Series B in 2019
We manage the whole process of short-rental, giving to our clients and their guests a high quality service. We enhance our client to earn money and time. Reservations, checkin, checkout, laundry and cleaning. We deal with just about anything!

Talent Garden

Series B in 2019
Talent Garden is a leading digital skills academy in Europe, established in Italy in 2011. It focuses on providing individuals and organizations with the necessary knowledge, spaces, and resources to thrive in the digital economy. The company offers a variety of learning experiences through online, offline, and hybrid courses, as well as corporate programs and events. Talent Garden operates a network of coworking campuses that foster a vibrant community of over 45,000 digital and tech professionals, including startups, agencies, and freelancers. Its mission is to empower people and organizations to navigate digital transformation effectively. By closing the digital skills gap, Talent Garden has trained more than 25,000 professionals in areas such as digital design, marketing, data analytics, and cybersecurity. The company also collaborates with major partners, including global corporations and institutions, to develop tailored corporate education programs. Its campuses, open 24 hours a day, are designed to facilitate collaboration and provide professionals with a conducive environment for growth and innovation.

Travel Appeal

Series A in 2018
Travel Appeal specializes in providing businesses with tools to navigate the complexities of data and enhance customer experiences. By offering data-driven insights, the company empowers professionals to understand customer behaviors and improve operational performance. Their technology incorporates a variety of advanced analytics, including predictive analysis, image and video recognition, and semantic analysis. Travel Appeal focuses on Human Experience Intelligence, utilizing a unique combination of geographical data, online feedback, and customer purchasing trends on a global scale. The company aims to democratize access to data, making it easier for businesses to utilize and comprehend in order to better serve their customers.

Easy Rain

Series A in 2017
Easy Rain i.S.p.A. is an Italian company founded in 2013, based in Milan, that specializes in enhancing vehicle safety through innovative technology. It has developed a patented active safety system that addresses the hydroplaning phenomenon, which occurs when vehicles lose traction on wet roads due to a layer of water. This issue contributes to millions of accidents annually and poses significant challenges for autonomous driving technologies. Easy Rain’s system prevents excessive water from contacting the tires, thereby improving traction and overall vehicle performance in wet conditions. The company holds extensive patent coverage for its technology and offers solutions that can integrate with remote detection and vision systems to further enhance safety and efficiency for both conventional and electric vehicles.

Directa Plus

Venture Round in 2015
Directa Plus S.p.A. is a technology company based in Lomazzo, Italy, that specializes in the production and supply of graphene-based products for various industrial and commercial applications. Founded in 2005, the company operates through segments including Textile, Environmental, and Others, offering products under its G+ brand. Its graphene-based solutions are utilized in a range of applications such as elastomers, smart textiles, wastewater treatment, composite materials, and 3D printing. Directa Plus also focuses on developing innovative manufacturing processes for nanostructures, emphasizing sustainability and performance in its product offerings. The company serves both domestic and international markets, with a significant portion of its revenue generated from the environmental segment.

Cellply

Seed Round in 2014
Cellply is a life-science company dedicated to advancing personalized cancer treatment through the development of innovative analytical tools. The company focuses on creating next-generation diagnostic platforms that enable deep characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics. By utilizing proprietary microfluidic technologies and Co-Culture Array technology, Cellply offers highly automated analytical instruments that combine AI-powered image and data analytics. This approach allows for the precise definition of immune system functions at the single-cell level, facilitating the monitoring of clinical responses to treatments. By automating quality control and supporting research and development processes, Cellply aims to enhance the understanding and effectiveness of novel cancer therapies, ultimately improving patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.